Plasma Concentration of Soluble Intercellular Adhesion Molecule-1 (sICAM-1) is Elevated in Type 2 Diabetic Patients, and sICAM-1 Synthesis is Associated with Leptin-Induced Activation of the Mitogen-Activated Protein Kinase (MAPK) Pathway
- 358 Downloads
The intercellular adhesion molecule-1 (ICAM-1) and leptin are important inflammatory biomarkers. We investigated whether plasma-soluble ICAM-1 levels were related to the diabetic nephropathy and systemic inflammation. One hundred forty-seven type 2 diabetic patients and 46 healthy control subjects were studied. Plasma sICAM-1 concentrations were significantly higher in the diabetic groups than controls and increased significantly as diabetic nephropathy advanced. Plasma sICAM-1 levels were positively correlated with body mass index, fasting and postprandial blood glucose, urinary albumin excretion, and negatively correlated with creatinine clearance. Multiple regression analysis showed that plasma leptin levels were associated with a significant increase in plasma sICAM-1 levels. In cultured HUVECs, leptin increased ICAM-1 production in a dose-dependent manner, and this stimulating effect of leptin on ICAM-1 expression was reversed by MEK inhibitor, PD98059. Overall, these findings suggest that activation of leptin synthesis in a diabetic environment promotes ICAM-1 activation via mitogen-activated protein kinase pathway in type 2 diabetic patients.
Key wordsdiabetic nephropathy HUVECs ICAM-1 leptin type 2 diabetic patients
This work was supported by the Brain Korea 21 project in 2012.
Conflict of interest
The authors state that there is no conflict of interest for this study.
- 6.Kent Jr., J.W., A.G. Comuzzie, M.C. Mahaney, L. Almasy, D.L. Rainwater, J.L. VandeBerg, J.W. MacCluer, and J. Blangero. 2004. Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in Mexican Americans. Diabetes 53: 2691–2695.PubMedCrossRefGoogle Scholar
- 10.Piconi, L., L. Quagliaro, R. Da Ros, R. Assaloni, D. Giugliano, K. Esposito, C. Szabó, and A. Ceriello. 2004. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. Journal of Thrombosis and Haemostasis 2: 1453–1459.PubMedCrossRefGoogle Scholar
- 14.Sierra-Johnson, J., A. Romero-Corral, F. Lopez-Jimenez, A.S. Gami, F.H. Sert Kuniyoshi, R. Wolk, and V.K. Somers. 2007. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population. The American Journal of Cardiology 100: 234–239.PubMedCrossRefGoogle Scholar
- 18.Bouloumie, A., T. Marumo, M. Lafontan, and R. Busse. 1999. Leptin induces oxidative stress in human endothelial cells. The FASEB Journal 13: 1231–1238.Google Scholar
- 19.Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Suppl 1): S5-S20.Google Scholar
- 20.Kishida, K., T. Funahashi, and I. Shimomura. 2011. Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease—lesson from the Amagasaki Visceral Fat Study: a Japanese perspective. Nutrition and Metabolism 16: 8–57.Google Scholar
- 24.Longo, D.L., and T.R. Harrison. 2012. Harrison’s principles of internal medicine, 18th ed, 1983–1992. New York: McGraw-Hill.Google Scholar
- 28.Aleffi, S., I. Petrai, C. Bertolani, M. Parola, S. Colombatto, E. Novo, F. Vizzutti, F.A. Anania, S. Milani, K. Rombouts, G. Laffi, M. Pinzani, and F. Marra. 2005. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 42: 1339–1348.PubMedCrossRefGoogle Scholar